In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
CJ Villabona-Arenas, N Vidal, E Guichet, L Serrano… - Aids, 2016 - journals.lww.com
Objective: In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
CJ Villabona-Arenas, N Vidal, E Guichet… - AIDS. Official journal of …, 2016 - hal.science
OBJECTIVE: In resource-limited countries, antiretroviral therapy (ART) has been scaled up,
but individual monitoring is still suboptimal. Here, we studied whether or not ART had an …
but individual monitoring is still suboptimal. Here, we studied whether or not ART had an …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in west and Central Africa.
CJ Villabona-Arenas, N Vidal, E Guichet, L Serrano… - 2016 - cabidigitallibrary.org
Objective: In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
CJ Villabona-Arenas, N Vidal… - AIDS (London …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
CJ Villabona-Arenas, N Vidal, E Guichet, L Serrano… - 2016 - documentation.ird.fr
Objective: In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
CJ Villabona-Arenas, N Vidal, E Guichet… - AIDS (London …, 2016 - europepmc.org
Objective In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
CJ Villabona-Arenas, N Vidal, E Guichet, L Serrano… - AIDS, 2016 - ingentaconnect.com
Objective: In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
CJ Villabona-Arenas, N Vidal, E Guichet, L Serrano… - 2016 - documentation.ird.fr
Objective: In resource-limited countries, antiretroviral therapy (ART) has been scaled up, but
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …
individual monitoring is still suboptimal. Here, we studied whether or not ART had an impact …